Document is current
Any future updates will be listed below
-
Authors
Ray-Jones, Helen https://orcid.org/0000-0002-8884-6865
Sung, Chak Kei
Chan, Lai Ting https://orcid.org/0009-0008-2600-1710
Haglund, Alexander https://orcid.org/0000-0003-0404-0723
Artemov, Pavel
Della Rosa, Monica
Ruje, Luminita
Burden, Frances
Kreuzhuber, Roman https://orcid.org/0000-0002-0762-0806
Litovskikh, Anna https://orcid.org/0000-0002-7017-1767
Weyenbergh, Eline
Brusselaers, Zoï
Tan, Vanessa Xue Hui
Frontini, Mattia https://orcid.org/0000-0001-8074-6299
Wallace, Chris https://orcid.org/0000-0001-9755-1703
Malysheva, Valeriya
Bottolo, Leonardo https://orcid.org/0000-0002-6381-2327
Vigorito, Elena https://orcid.org/0000-0001-6230-3849
Spivakov, Mikhail https://orcid.org/0000-0002-0383-3943
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC-A652-5QA20, MC_UU_00002/4, MR/W029790/1, MC_UU_00002/4)
British Heart Foundation (FS/18/53/33863, RE/18/1/34212)
Wellcome Trust (WT220788)
RCUK | Engineering and Physical Sciences Research Council (EP/N510129/1)
- License Information
-
More Information
Article History
Received: 21 August 2024
Accepted: 3 January 2025
First Online: 27 January 2025
Competing interests
: M.S. is a shareholder of Enhanc3D Genomics Ltd. C.W. is supported by GSK and MSD and is a part-time employee of GSK. GSK had no role in this study or the decision to publish. The remaining authors declare no competing interests.
